Gene · 3229
Papers1,422
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,422
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Membrane Pore Size on Membrane Fouling of Corundum Ceramic Membrane in MBR. | Int J Environ Res Public Health | 2023 | 36901568 | PubTator, text mining | PubMed |
| Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. | Diagnostics (Basel) | 2023 | 36900028 | PubTator, text mining | PubMed |
| lncHUB2: aggregated and inferred knowledge about human and mouse lncRNAs. | Database (Oxford) | 2023 | 36869839 | PubTator, text mining | PubMed |
| Human skin specific long noncoding RNA HOXC13-AS regulates epidermal differentiation by interfering with Golgi-ER retrograde transport. | Cell Death Differ | 2023 | 36869179 | PubTator, text mining | PubMed |
| The Study of the Acoustic Characteristics of Chitosan Acetate Film Using a Radial Electric Field Excited Resonator. | Sensors (Basel) | 2023 | 36850404 | PubTator, text mining | PubMed |
| The immune-metabolic crosstalk between CD3+C1q+TAM and CD8+T cells associated with relapse-free survival in HCC. | Front Immunol | 2023 | 36845133 | PubTator, text mining | PubMed |
| The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. | Int J Mol Sci | 2023 | 36835628 | PubTator, text mining | PubMed |
| PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions. | Int J Mol Sci | 2023 | 36834531 | PubTator, text mining | PubMed |
| Variants Identified in the HOXC13 and HOXD13 Genes Suggest Association with Cervical Cancer in a Cohort of Mexican Women. | Genes (Basel) | 2023 | 36833285 | PubTator, text mining | PubMed |
| Role of LGMN in tumor development and its progression and connection with the tumor microenvironment. | Front Mol Biosci | 2023 | 36825203 | PubTator, text mining | PubMed |
| Identifying important gene signatures of BMI using network structure-aided nonparametric quantile regression. | Stat Med | 2023 | 36822218 | PubTator, text mining | PubMed |
| A narrative review: narrow-band imaging endoscopic classifications. | Quant Imaging Med Surg | 2023 | 36819279 | PubTator, text mining | PubMed |
| Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer. | Front Oncol | 2023 | 36814821 | PubTator, text mining | PubMed |
| Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules. | Parasit Vectors | 2023 | 36797792 | PubTator, text mining | PubMed |
| Application of Novel Breast Biospecimen Cell-Type Adjustment Identifies Shared DNA Methylation Alterations in Breast Tissue and Milk with Breast Cancer-Risk Factors. | Cancer Epidemiol Biomarkers Prev | 2023 | 36780234 | PubTator, text mining | PubMed |
| Synthesis of an amantadine-based novel Schiff base and its transition metal complexes as potential ALP, α-amylase, and α-glucosidase inhibitors. | RSC Adv | 2023 | 36756442 | PubTator, text mining | PubMed |
| Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics. | Clin Cancer Res | 2023 | 36749875 | PubTator, text mining | PubMed |
| Expression Profiles, Prognosis, and ceRNA Regulation of SRY-Related HMG-Box Genes in Stomach Adenocarcinoma. | J Environ Pathol Toxicol Oncol | 2023 | 36749091 | PubTator, text mining | PubMed |
| Physiological changes associated with copper sulfate-induced nausea and retching in felines. | Front Physiol | 2023 | 36744037 | PubTator, text mining | PubMed |
| MHCing the tumour's dark genome. | Nat Rev Immunol | 2023 | 36737656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3229/papers?page=8